Influence of additives on swelling and mucoadhesion properties of glyceryl monooleate liquid crystals

Autores

  • Ana Beatriz Cintra School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, SP, Brazil
  • Lariani Aparecida Delboni School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, SP, Brazil
  • Marilisa Guimarães Lara School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, SP, Brazil https://orcid.org/0000-0002-7411-5762

DOI:

https://doi.org/10.1590/s2175-97902022e20803

Palavras-chave:

Glyceryl monooleate, Liquid crystals, Drug delivery, Swelling, Mucoadhesion, Buccal drug delivery

Resumo

Liquid crystalline systems of glyceryl monooleate/water are used as drug delivery systems due to their complex structure that controls drug diffusion. Mucoadhesive properties of glyceryl monooleate suggest it can be used for buccal delivery. Using additives is a strategy to modify physical and chemical properties of liquid crystalline systems and optimize their performance
as a drug delivery system. However, the presence of additives can significantly alter properties such as phase behavior, swelling and mucoadhesion. Our aim is to investigate the influence of additives on swelling and mucoadhesion of glyceryl monooleate-based liquid crystals, intending them to be used as buccal drug delivery systems. The systems were characterized regarding their mesophases, swelling rate, and mucoadhesion. All the systems studied were able to absorb water and presented mucoadhesion, which is interesting for the development of buccal drug delivery systems. Additives induced phase transitions and affected the swelling performance, while mucoadhesive properties were poorly affected. Propylene glycol increased water uptake, while oleic acid induced the phase transition to the hexagonal phase and reduced the swelling rate. The association of oleic acid (5%) and propylene glycol (10%) resulted in a cubic phase system with strong mucoadhesive properties that can be a potential drug carrier for buccal delivery.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

Alfons K, Engström S. Drug compatibility with the sponge

phases formed in monoolein, water, and propylene glycol or

poly(ethylene glycol). J Pharm Sci. 1998;87(12):1527–30.

Bender J, Ericson MB, Merclin N, Iani V, Rosén A, Engström

S, et al. Lipid cubic phases for improved topical drug

delivery in photodynamic therapy. J Controlled Release.

;106(3):350–60.

Bender J, Jarvoll P, Nydén M, Engström S. Structure

and dynamics of a sponge phase in the methyl deltaaminolevulinate/monoolein/water/propylene glycol system.

J Colloid Interface Sci. 2008;317(2):577–84.

Bisset NB, Boyd BJ, Dong Y. Tailoring liquid crystalline

lipid nanomaterials for controlled release of macromolecules.

Int J Pharm. 2015;495(1):241–8.

Boyd BJ, Whittaker DV, Khoo S-M, Davey G. Lyotropic

liquid crystalline phases formed from glycerate surfactants

as sustained release drug delivery systems. Int J Pharm.

;309(1-2):218–26.

Brasnett C, Longstaff G, Compton L, Seddon A. Effects

of cations on the behaviour of lipid cubic phases. Sci Rep.

;7:8229.

Carvalho FC, Bruschi ML, Evangelista RC, Gremião MPD.

Mucoadhesive drug delivery systems. Brazilian J Pharm Sci.

;46(1):1–17.

Chang C-M, Bodmeier R. Effect of dissolution media and

additives on the drug release from cubic phase delivery

systems. J Controlled Release. 1997;46(3):215–22.

Dante M de CL, Borgheti-Cardoso LN, Fantini MC de

A, Praça FSG, Medina WSG, Pierre MBR, et al. Liquid

crystalline systems based on glyceryl monooleate and

penetration enhancers for skin delivery of celecoxib:

characterization, in vitro drug release, and in vivo studies. J

Pharm Sci. 2018;107(3):870–8.

Dash AK, Gong Z, Miller DW, Huai-Yan H, Laforet JP.

Development of a rectal nicotine delivery system for the

treatment of ulcerative colitis. Int J Pharm. 1999;190(1):21–

Esposito E, Carducci F, Mariani P, Huang N, Simelière F,

Cortesi R, et al. Monoolein liquid crystalline phases for

topical delivery of crocetin. Colloids Surf B. 2018;171:67–74.

Esposito E, Carotta V, Scabbia A, Trombelli L, D’Antona

P, Menegatti E, et al. Comparative analysis of tetracyclinecontaining dental gels: Poloxamer- and monoglyceride-based

formulations. Int J Pharm. 1996;142(1):9–23.

Guo C, Wang J, Cao F, Lee RJ, Zhai G. Lyotropic liquid

crystal systems in drug delivery. Drug Discov Today.

;15(23-24):1032–40.

Kumar M. K, Shah MH, Ketkar A, Mahadik KR, Paradkar A.

Effect of drug solubility and different excipients on floating

behaviour and release from glyceryl monooleate matrices.

Int J Pharm 2004;272(1-2):151–60.

Lara MG, Bentley MVLB, Collett JH. In vitro drug release

mechanism and drug loading studies of cubic phase gels. Int

J Pharm. 2005;293(1-2):241–50.

Lee J, Choi SU, Yoon MK, Choi YW. Kinetic characterization

of swelling of liquid crystalline phases of glyceryl

monooleate. Arch Pharm Res. 2003;26:880–5.

Lee J, Kellaway IW. Combined effect of oleic acid and

polyethylene glycol 200 on buccal permeation of [D-Ala2,

D-Leu5]enkephalin from a cubic phase of glyceryl

monooleate. Int J Pharm. 2000;204(1-2):137–44.

Lee J, Young SA, Kellaway IW. Water quantitatively induces

the mucoadhesion of liquid crystalline phases of glyceryl

monooleate. J Pharm Pharmacol. 2001;53(5):629–36.

Li Q, Cao J, Li Z, Chu X. Cubic Liquid Crystalline Gels

Based on Glycerol Monooleate for Intra-articular Injection.

AAPS Pharm Sci Tech. 2018;19(2):858–65.

Libster D, Aserin A, Garti N. Interactions of

biomacromolecules with reverse hexagonal liquid crystals:

Drug delivery and crystallization applications. J Colloid

Interface Sci. 2011;356(2):375–86.

Lopes LB, Lopes JLC, Oliveira DCR, Thomazini JA, Garcia

MTJ, Fantini MC de A, et al. Liquid crystalline phases of

monoolein and water for topical delivery of cyclosporin A:

Characterization and study of in vitro and in vivo delivery.

Eur J Pharm Biopharm. 2006;63(2):146–55.

Madheswaran T, Baskaran R, Thapa RK, Rhyu JY, Choi HY,

Kim JO, et al. Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery.

AAPS Pharm Sci Tech. 2013;14(1):45–52.

Merclin N, Bender J, Sparr E, Guy RH, Ehrsson H,

Engström S. Transdermal delivery from a lipid sponge

phase--iontophoretic and passive transport in vitro of

-aminolevulinic acid and its methyl ester. J Controlled

Release. 2004;100(2):191–8.

Milak S, Zimmer A. Glycerol monooleate liquid crystalline

phases used in drug delivery systems. Int J Pharm.

;478(2):569–87.

Nakamoto, RY. Use of a saliva substitute in postradiation

xerostomia. J of Prost Dent. 1979;42(5):539-542.

Nielsen LS, Schubert L, Hansen J. Bioadhesive drug delivery

systems. I. Characterisation of mucoadhesive properties

of systems based on glyceryl mono-oleate and glyceryl

monolinoleate. Eur J Pharm Sci. 1998;6(3):231–9.

Norling T, Lading P, Engström S, Larsson K, Krog N,

Nissen SS. Formulation of a drug delivery system based

on a mixture of monoglycerides and triglycerides for use

in the treatment of periodontal disease. J Clin Periodontol.

;19(9 Pt2):687–92.

Nunes KM, Teixeira CCC, Kaminski RCK, Sarmento VHV,

Couto RO, Pulcinelli SH, et al. The monoglyceride content

affects the self-assembly behavior, rheological properties,

syringeability, and mucoadhesion of in situ–gelling liquid

crystalline phase. J Pharm Sci. 2016;105(8):2355–64.

Okonogi S, Khongkhunthain S, Bunyaratavej P, Thusaphorn

T, Umpriwan R. Development of local injectable dental

gel: the influence of certain additives on physicochemical

properties of glycerylmonooleate-based formulations. Drug

Dev Ind Pharm. 2004;30(4):347–57.

Peng X, Wen X, Pan X, Wang R, Chen B, Wu C. Design and in

vitro evaluation of capsaicin transdermal controlled release

cubic phase gels. AAPS PharmSciTech. 2010;11(3):1405–10.

Phan S, Fong WK, Kirby N, Hanley T, Boyd BJ. Evaluating

the link between self-assembled mesophase structure and

drug release. Int J Pharm. 2011;421(1):176–82.

Rajabalaya R, Musa MN, Kifli N, David SR. Oral and

transdermal drug delivery systems: Role of lipid-based

lyotropic liquid crystals. Drug Des Devel Ther. 2017;11:393–

Rizwan SB, Hanley T, Boyd BJ, Rades T, Hook S. Liquid

crystalline systems of phytantriol and glyceryl monooleate

containing a hydrophilic protein: Characterisation, swelling

and release kinetics. J Pharm Sci. 2009;98(11):4191–204.

Sallam AS, Khalil E, Ibrahim H, Freij I. Formulation of

an oral dosage form utilizing the properties of cubic liquid

crystalline phases of glyceryl monooleate. Eur J Pharm

Biopharm. 2002;53(3):343–52.

Schott H. Kinetics of swelling of polymers and their gels. J

Pharm Sci. 1992;81(5):467–70.

Shah MH, Paradkar A. Effect of HLB of additives on the

properties and drug release from the glyceryl monooleate

matrices. Eur J Pharm Biopharm. 2007;67(1):166–74.

Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug

delivery systems. Adv Drug Deliv Rev. 2001;47(2-3):229–50.

Smart JD. The basics and underlying mechanisms of

mucoadhesion. Adv Drug Deliv Ver. 2005;57(11):1556–68.

Souza C, Watanabe E, Borgheti-Cardoso LN, Fantini MC de

A, Lara MG. Mucoadhesive system formed by liquid crystals

for buccal administration of poly(hexamethylene biguanide)

hydrochloride. J Pharm Sci 2014;103(12):3914–23.

Wang X, Zhang Y, Gui S, Huang J, Cao J, Li Z, et al.

Characterization of lipid-based lyotropic liquid crystal and

effects of guest molecules on its microstructure: a systematic

review. AAPS Pharm Sci Tech. 2018;19(5):2023–40.

Zabara A, Mezzenga R. Controlling molecular transport

and sustained drug release in lipid-based liquid crystalline

mesophases. J Controlled Release. 2014;188:31–43.

Downloads

Publicado

2023-01-27

Edição

Seção

Original Article

Como Citar

Influence of additives on swelling and mucoadhesion properties of glyceryl monooleate liquid crystals. (2023). Brazilian Journal of Pharmaceutical Sciences, 58. https://doi.org/10.1590/s2175-97902022e20803